Earlier today, the ABC flagged a shift in their position on generative artificial intelligence (AI) use in their news ...
The Wider Maboneng Improvement District operates alongside informal activity to address failing infrastructure, safety ...
AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the ...